Aldox,
M-dimethylamine,
MADP solution,
myristamidopropyl dimethylamine,
45267-19-4,
N-(3-(Dimethylamino)propyl)tetradecanamide,
Myristamidopropyl dimethylamine,
N-[3-(Dimethylamino)propyl]myristamide,
Aldox,
UNII-YXS2X34V8W,
Tetradecanamide, N-[3-(dimethylamino)propyl]-,
Dimethylaminopropyl myristamide,
N-[3-(dimethylamino)propyl]tetradecanamide,
YXS2X34V8W,
Tetradecanamide, N-(3-(dimethylamino)propyl)-,
N-(3-(Dimethylamino)propyl)myristamide,
Schercodine M,
Myristic 3-dimethylaminopropylamide,
EINECS 256-214-1,
Lexamine M 13,
N,N-Dimethyl-(3-tetradecylamidopropyl)amine,
SCHEMBL94326,
DTXSID2068470,
CTK8I7760,
IFYDWYVPVAMGRO-UHFFFAOYSA-N,
AC1L5672,
MFCD02029644,
STL377897,
ZINC72399333,
AKOS003262148,
MCULE-4094535184,
KS-000001S1,
N-(3-Dimethylaminopropyl)tetradecanamide,
FT-0661482,
ST45005600,
N,N-Dimethyl-N'-Tetradecanoyl-1,3-Propylenediamine,
UNII-L36BM7DG2T component IFYDWYVPVAMGRO-UHFFFAOYSA-N,
C19H40N2O,
C19-H40-N2-O,
CID170759,
N- [3- (dimethylamino)propyl]myristamide,